| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea0de26b3bb22f02747a50127aba633 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b663575f321fd972c4560cc6bf10f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3310fa56fe64d55afaea16ac9fc191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fde849f29378ccd1c89ef17af046dee |
| publicationDate |
2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10434144-B2 |
| titleOfInvention |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders |
| abstract |
Provided herein are methods of using 7a-hydroxy-4-cholsten-3-one (C4) in predicting the clinical sensitivity to treatment of bile acid-related and associated disorders with treatment peptides, such as variants of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics) and fusions of FGF19 and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), and variants of fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564972-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11370841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758590-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022072099-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020164036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11141460-B2 |
| priorityDate |
2014-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |